Pub Date : 2022-04-06DOI: 10.1108/dhs-02-2021-0008
A. Castelló, Hugo Rafael Silva, K. Areco, Paulo Paiva, D. D. da Silveira
Purpose The purpose of this study was to investigate the relationship between parenting styles, family psychological vulnerability environment (FPVE) and drug use among adolescents. Design/methodology/approach The quantitative survey using paper and pencil was administered to collect data from 284 parents registered with a paediatric clinic in the city of São Paulo (Brazil), most of whom claimed that their children used drugs. FPVE was measured by eight scales: family relationship patterns and drug use habits; hereditary predisposition to drug use; transmission of moral values to children (reverse); parents’ hereditary predisposition; parental drug use; depression; impulsiveness; and anxiety. Findings Dimensions of FPVE that had an effect on drug use by adolescents were: the family relationship and drug use patterns of the family of procreation, drug use by the parents and heredity in relation to drug use. Conversely, the family relationship and drug use patterns of the family of origin and the parents’ anxiety, symptoms of depression and impulsiveness did not affect their children’s drug use. Research limitations/implications One limitation of this study is the sample of parents. These parents were parents of adolescents who were on psychological treatment. The authors do not know if part of parents who declared that their children do not are drugs user, because the treatment effect. Another limitation is that the authors did not compare the effect of parents’ drugs misuse with parents who do not use drugs on adolescents’ drugs use. One other limit is that the authors treated the parents regardless of they were mothers and fathers. Originality/value This study expands the study of the antecedents on drug use by adolescents, considering FPVE as a construct. Regarding this construct, when facing resources limitation, the practitioners can prioritize strategies to prevent adolescents’ drug use.
{"title":"Vulnerability, transgenerationality, parenting styles and use of psychoactive substances by adolescents","authors":"A. Castelló, Hugo Rafael Silva, K. Areco, Paulo Paiva, D. D. da Silveira","doi":"10.1108/dhs-02-2021-0008","DOIUrl":"https://doi.org/10.1108/dhs-02-2021-0008","url":null,"abstract":"\u0000Purpose\u0000The purpose of this study was to investigate the relationship between parenting styles, family psychological vulnerability environment (FPVE) and drug use among adolescents.\u0000\u0000\u0000Design/methodology/approach\u0000The quantitative survey using paper and pencil was administered to collect data from 284 parents registered with a paediatric clinic in the city of São Paulo (Brazil), most of whom claimed that their children used drugs. FPVE was measured by eight scales: family relationship patterns and drug use habits; hereditary predisposition to drug use; transmission of moral values to children (reverse); parents’ hereditary predisposition; parental drug use; depression; impulsiveness; and anxiety.\u0000\u0000\u0000Findings\u0000Dimensions of FPVE that had an effect on drug use by adolescents were: the family relationship and drug use patterns of the family of procreation, drug use by the parents and heredity in relation to drug use. Conversely, the family relationship and drug use patterns of the family of origin and the parents’ anxiety, symptoms of depression and impulsiveness did not affect their children’s drug use.\u0000\u0000\u0000Research limitations/implications\u0000One limitation of this study is the sample of parents. These parents were parents of adolescents who were on psychological treatment. The authors do not know if part of parents who declared that their children do not are drugs user, because the treatment effect. Another limitation is that the authors did not compare the effect of parents’ drugs misuse with parents who do not use drugs on adolescents’ drugs use. One other limit is that the authors treated the parents regardless of they were mothers and fathers.\u0000\u0000\u0000Originality/value\u0000This study expands the study of the antecedents on drug use by adolescents, considering FPVE as a construct. Regarding this construct, when facing resources limitation, the practitioners can prioritize strategies to prevent adolescents’ drug use.\u0000","PeriodicalId":72849,"journal":{"name":"Drugs, habits and social policy","volume":"56 79 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84081186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-15DOI: 10.1108/dhs-11-2021-0060
Kenzi Riboulet-Zemouli, Michael Krawitz
Background “Cannabis” and “cannabis resin” are derived from the Cannabis plant, used as herbal medications, in traditional medicine and as active pharmaceutical ingredients. Since 1961, they have been listed in Schedule IV, the most restrictive category of the single convention on narcotic drugs. The process to scientifically review and reschedule them was launched by the World Health Organisation (WHO) on 2 December 2016; it survived a number of hindrances until finally being submitted to a delayed and sui generis vote by the UN Commission on Narcotic Drugs on 2 December 2020, withdrawing “cannabis” and “cannabis resin” from Schedule IV. Design/methodology/approach To evaluate WHO’s scheduling recommendations, the process leading to the Commission vote and subsequent implications at global, national and patient/clinician levels. Narrative account of the four-year proceedings; review of the practical implications of both rejected and accepted recommendations. Findings The process was historically unprecedented, of political relevance to both medical Cannabis and evidence-based scheduling generally. Procedural barriers hampered the appropriate involvement of civil society stakeholders. The landscape resulting from accepted and rejected recommendations allow countries to continue creating decentralised, non-uniform systems for access to and availability of “cannabis” and “cannabis resin” for medical purposes. Originality/value Perspective of accredited observers; highlight of institutional issues and the lay of the land; contrast of stakeholders’ interpretations and engagement.
{"title":"WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications","authors":"Kenzi Riboulet-Zemouli, Michael Krawitz","doi":"10.1108/dhs-11-2021-0060","DOIUrl":"https://doi.org/10.1108/dhs-11-2021-0060","url":null,"abstract":"\u0000Background\u0000“Cannabis” and “cannabis resin” are derived from the Cannabis plant, used as herbal medications, in traditional medicine and as active pharmaceutical ingredients. Since 1961, they have been listed in Schedule IV, the most restrictive category of the single convention on narcotic drugs. The process to scientifically review and reschedule them was launched by the World Health Organisation (WHO) on 2 December 2016; it survived a number of hindrances until finally being submitted to a delayed and sui generis vote by the UN Commission on Narcotic Drugs on 2 December 2020, withdrawing “cannabis” and “cannabis resin” from Schedule IV.\u0000\u0000\u0000Design/methodology/approach\u0000To evaluate WHO’s scheduling recommendations, the process leading to the Commission vote and subsequent implications at global, national and patient/clinician levels. Narrative account of the four-year proceedings; review of the practical implications of both rejected and accepted recommendations.\u0000\u0000\u0000Findings\u0000The process was historically unprecedented, of political relevance to both medical Cannabis and evidence-based scheduling generally. Procedural barriers hampered the appropriate involvement of civil society stakeholders. The landscape resulting from accepted and rejected recommendations allow countries to continue creating decentralised, non-uniform systems for access to and availability of “cannabis” and “cannabis resin” for medical purposes.\u0000\u0000\u0000Originality/value\u0000Perspective of accredited observers; highlight of institutional issues and the lay of the land; contrast of stakeholders’ interpretations and engagement.\u0000","PeriodicalId":72849,"journal":{"name":"Drugs, habits and social policy","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79421600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-14DOI: 10.1108/dhs-09-2021-0046
Heino Stöver, I. Michels
Purpose This study aims to report on the findings of a pilot study of the prevalence and treatment of infectious diseases among people who inject drugs in Kazakhstan and Kyrgyzstan. Design/methodology/approach This study reports on study results based on two data collection methods: quantitative surveys and complimentary qualitative interviews. Findings The findings show that the role of social work in the region is crucial for establishing trust between non-governmental and civil society organizations and the state as exemplified by so-called “trust points” and “friendly cabinets.” Originality/value Firstly, this study provides an overview of injecting drug use and the prevalence statistics on infectious diseases. Following this, this study focuses on the treatment and prevention of the spread of HIV/AIDS and HCV. Both areas are under-researched and address the gap in the literature on drug policy in Central Asia.
{"title":"Development of social work in prevention and treatment of HIV/AIDS and HCV in Central Asia","authors":"Heino Stöver, I. Michels","doi":"10.1108/dhs-09-2021-0046","DOIUrl":"https://doi.org/10.1108/dhs-09-2021-0046","url":null,"abstract":"\u0000Purpose\u0000This study aims to report on the findings of a pilot study of the prevalence and treatment of infectious diseases among people who inject drugs in Kazakhstan and Kyrgyzstan.\u0000\u0000\u0000Design/methodology/approach\u0000This study reports on study results based on two data collection methods: quantitative surveys and complimentary qualitative interviews.\u0000\u0000\u0000Findings\u0000The findings show that the role of social work in the region is crucial for establishing trust between non-governmental and civil society organizations and the state as exemplified by so-called “trust points” and “friendly cabinets.”\u0000\u0000\u0000Originality/value\u0000Firstly, this study provides an overview of injecting drug use and the prevalence statistics on infectious diseases. Following this, this study focuses on the treatment and prevention of the spread of HIV/AIDS and HCV. Both areas are under-researched and address the gap in the literature on drug policy in Central Asia.\u0000","PeriodicalId":72849,"journal":{"name":"Drugs, habits and social policy","volume":"3 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80732054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-03DOI: 10.1017/9781108682312.013
Mark Johnson
{"title":"Moral Habit","authors":"Mark Johnson","doi":"10.1017/9781108682312.013","DOIUrl":"https://doi.org/10.1017/9781108682312.013","url":null,"abstract":"","PeriodicalId":72849,"journal":{"name":"Drugs, habits and social policy","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81895242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：